RESEARCH & INNOVATION SHOWCASE Dr Jill Madine

Slides:

Advertisements

Similar presentations

Carcinogenesis Cardiovascular Disease Cardiovascular Disease Rheumatoid Arthritis Alzheimer’s Disease Alzheimer’s Disease Athersclerosis Diabetes Xenobiotic.

Advertisements

ALS Research Yesterday, Today and Tomorrow Heather D. Durham, PhD.

Metabonomics A New Potential Diagnostic Tool David Huffman Western Michigan University WDA 2010.

OXIDATIVE STRESS. INDUCTION OF OXIDATIVE STRESS Glutathione conjugation MalnutritionMutation Phagocytic activation Tissue damageSmoking.

The following is an animation demonstrating the effects of prions on neuronal cells. Prions are misfolded proteins which provoke an array of neurodegenerative.

C-REACTIVE PROTEIN, FIBRINOGEN, AND CARDIOVASCULAR DISEASE PREDICTION By Patrick Whitledge PA-S2 South University Physician Assistant Program.

Howard Fillit, MD Executive Director Improving Animal Trials for Alzheimer’s Disease: Recommendations for Best Practices.

A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.

1 Batten animal research Network :Lincoln NZ Finnish and Variant Late Infantile Batten Disease David Palmer, Lucy Barry, Hannah Lee, Nadia Mitchell, Janet.

COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.

NOW WHERE HAVE I PUT MY GLASSES? A DISCUSSION AROUND DEMENTIA Dr Marion Overton U3A SCIENCE 19TH JUNE 2015.

Intellectual Property Dr Laura Rush Business Development Manager Research Enterprise Services copyright©NewcastleUniversity 2015.

First Annual Meeting. Pioneering the Use of Genomic Biomarkers in Assessing Risk to Environmental and Human Health An established and effective collaboration.

Fellow: Mary Boggs Teacher: Phyllis Meyer Biology Funded by National Science Foundation Graduate Teaching Fellows Program in K-12 Education (GK-12) DGE.

Funding Opportunities Pfizer - Centers for Therapeutic Innovation (CTI) RFA Coming Soon! Information Session: Monday, Sept 10, 1pm, Duncan Reid Conference.

A NTIBODY -B ASED T HERAPEUTICS FOR T REATING A LZHEIMER ’ S AND P ARKINSON ’ S D ISEASES Taylor Brownlee Dr. Michael Sierks Chemical Engineering 2012.

RESEARCH & INNOVATION SHOWCASE Dr Trish Murray Senior Lecturer in Stem Cell/Developmental Biology, ITM Senior scientist in the UK Regenerative Medicine.

External Events Accelerating EU-US Business Collaboration in Health/e- Health Research & Innovation: Opportunities, Barriers and Best Practices Friday,

Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.

RESEARCH & INNOVATION SHOWCASE Dr Lauren Walker MRC Clinical Training Fellow supported by the North West England MRC Fellowship Scheme in Clinical Pharmacology.

Single Cell Analysis Systems for Therapeutic Discovery

Biomedical Data Science for Precision Medicine

Next generation heparin therapeutics Research interests/expertise:

Dr Ing. Joseph Buhagiar, PhD Department of Metallurgy and Materials Engineering University of Malta, Malta Expertise in: Corrosion Science: With specialisation.

NISCHR Academic Health Science Collaboration Launch

Business Development Manager

COMBINATION OF CSF PROTEIN BIOMARKERS AND BDNF, IL10 AND IL6 GENOTYPES IN EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE Mirjana Babić Leko1, Matea Nikolac Perković2,

EU funding opportunities

BIONECA COST ACTION MEETING

Dr. Miguel Oliveira, PhD Principal Investigator, Pro-Director 3B´s Research Group, Member of the PT Government Associate Laboratory ICVS/3B’s University.

Joint WKRU and DRU Diabetic Nephropathy Research Symposium May 3rd, Aberdare Hall, Cardiff University Registration, Coffee Key.

Translational Research Laboratory

Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.

Histology of Nervous Tissue

RESEARCH & INNOVATION SHOWCASE Dr Marie M Phelan

Reduced Costs Service & Support Innovative Technology Performance Quality.

Reduced Costs Service & Support Innovative Technology Performance Quality.

“Proteomics is a science that focuses on the study of proteins: their roles, their structures, their localization, their interactions, and other factors.”

Judy Delp Biomedical Sciences

Human Health and Disease

کارگاه چگونگی پایش ثبت وقایع

Branko Stefanovic Biomedical Sciences

Bettina Schreiner, Melanie Greter Cell Stem Cell

Protein Misfolding, Amyloid Formation, and Neurodegeneration

Biomedical Data Science for Precision Medicine

Robert Zweigerdt, Ina Gruh, Ulrich Martin Cell Stem Cell

Yanchang Wang Biomedical Sciences

Conventional approach: Transducing tumor cells

Figure 1 Overview of biosimilar product development

Osteoarthritis year 2012 in review: biomarkers

Copyright © 2016 Elsevier Inc. All rights reserved.

Figure 3 VEGF in neurodegenerative disease

Severe Asthma and Comorbidities

Lung Cancer: A Wily Genetic Opponent

Types of biomarkers/biosignatures to be used for cardiovascular disease. Types of biomarkers/biosignatures to be used for cardiovascular disease. There.

Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration Smita Saxena, Pico Caroni Neuron Volume 71,

Volume 91, Issue 1, Pages 1-3 (July 2016)

Mechanisms Underlying Inflammation in Neurodegeneration

HOMA calculations where glucose is mmol/L and insulin is mU/L

Bettina Schreiner, Melanie Greter Cell Stem Cell

9th World Congress on Nursing and Healthcare Philadelphia, USA

Katharine James Clinical Neurosciences Research Unit

Chapter 18 Dietary Phytochemicals in Neurodegenerative Disease

Discovering and Designing New Materials Using Directed Evolution

Assessment of infarct size by biomarker measurement.

Diagram showing the normal progression of severe PPH

Diagram showing the normal progression of severe PPH

Оюутны эрдэм шинжилгээний хурлын зорилго:

-supported study By Dr. Chao Peng

Biomaterials Dr. Ahmed Moro.

Presentation transcript:

RESEARCH & INNOVATION SHOWCASE Dr Jill Madine British Heart Foundation Intermediate Basic Science Research Fellow 13 years experience working with amyloid proteins Neurodegenerative and cardiovascular diseases Poster B11

RESEARCH & INNOVATION SHOWCASE Dr Jill Madine NMR metabolomics to understand mechanisms underlying toxicity in neurodegenerative amyloid diseases Cell lines to generate a model to assess therapeutic avenues Neuroblastoma Other neuronal cells e.g. microglia, astrocytes Biomaterials for model verification and biomarker assay development Poster B11

RESEARCH & INNOVATION SHOWCASE Dr Jill Madine Funding for high throughput NMR metabolomics Collaboration opportunity to assess targeted therapeutics Biomarker development for early disease diagnosis Poster B11